1. Home
  2. SPRO vs BSBK Comparison

SPRO vs BSBK Comparison

Compare SPRO & BSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.24

Market Cap

124.5M

Sector

Health Care

ML Signal

HOLD

Logo Bogota Financial Corp.

BSBK

Bogota Financial Corp.

HOLD

Current Price

$8.34

Market Cap

109.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
BSBK
Founded
2013
1893
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
124.5M
109.6M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
SPRO
BSBK
Price
$2.24
$8.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
261.3K
6.2K
Earning Date
03-26-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
111.81
200.00
EPS
0.15
0.17
Revenue
$66,802,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.53
$75.00
Revenue Growth
39.24
N/A
52 Week Low
$0.51
$6.59
52 Week High
$3.09
$9.49

Technical Indicators

Market Signals
Indicator
SPRO
BSBK
Relative Strength Index (RSI) 39.83 52.21
Support Level $2.15 $8.05
Resistance Level $2.44 $8.60
Average True Range (ATR) 0.13 0.11
MACD -0.02 0.01
Stochastic Oscillator 4.35 60.00

Price Performance

Historical Comparison
SPRO
BSBK

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About BSBK Bogota Financial Corp.

Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from customers in New Jersey.

Share on Social Networks: